Following an extensive review, Belgian biotech Galapagos today revealed its intention to wind down its cell therapy business ...
Oncolytic immunotherapies specialist Replimune Group has announced that the US Food and Drug Administration (FDA) has ...
South Korea-based Samsung Bioepis and Chinese biotech start-up Phrontline Biopharma have entered into a global collaboration ...
US trade group the Research and Manufacturers of America (PhRMA) has hailed the impact of direct purchase programs (DPPs), ...
California, USA-based Alto Neuroscience saw its shares shoot up more than 80% to $11.00 yesterday, after it revealed it has ...
South Korea’s SK Biopharmaceuticals (KRX: 326030) has partnered with Brazil’s Eurofarma to launch Mentis Care, a ...
Swiss pharma giant Roche’s US subsidiary Genentech yesterday revealed that the US Food and Drug Administration (FDA) has ...
Five months after closing its Series B financing, USA-based NewLimit has raised an additional $45 million from Eli Lilly), ...
US contract manufacturer Life Science Outsourcing has appointed Doug Constable as chief executive to steer its next growth ...
Summit Therapeutics (Nasdaq: SMMT) said it plans to file a biologics license application in the fourth quarter for ...
Israeli pharma major Teva (NYSE: TEVA) has entered a licensing agreement with Singapore-based Prestige Biopharma (KOSDAQ: ...
German Merck KGaA’s recently acquired subsidiary SpringWorks Therapeutics today announced that long-term efficacy and safety data from the Phase III DeFi trial of Ogsiveo (nirogacestat) were in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback